List of Excipients in API doxercalciferol
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing doxercalciferol
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Hospira Inc | DOXERCALCIFEROL | doxercalciferol | 0409-1331 | ALCOHOL | |
| Hospira Inc | DOXERCALCIFEROL | doxercalciferol | 0409-1331 | BUTYLATED HYDROXYTOLUENE | |
| Hospira Inc | DOXERCALCIFEROL | doxercalciferol | 0409-1331 | EDETATE DISODIUM | |
| Hospira Inc | DOXERCALCIFEROL | doxercalciferol | 0409-1331 | POLYSORBATE 20 | |
| Hospira Inc | DOXERCALCIFEROL | doxercalciferol | 0409-1331 | SODIUM CHLORIDE | |
| Hospira Inc | DOXERCALCIFEROL | doxercalciferol | 0409-1331 | SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | |
| Hospira Inc | DOXERCALCIFEROL | doxercalciferol | 0409-1331 | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing doxercalciferol
Detailed excipient profiles for doxercalciferol
Excipient focus: ALCOHOL
doxercalciferol drug variants containing ALCOHOL
doxercalciferol drug variants not containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | doxercalciferol | 0641-6154 |
| >Company | >Ingredient | >NDC |
Excipient focus: AMMONIA
doxercalciferol drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| West-Ward Pharmaceuticals Corp | doxercalciferol | 0054-0338 |
| Rising Pharmaceuticals Inc | doxercalciferol | 64980-228 |
| >Company | >Ingredient | >NDC |
doxercalciferol drug variants not containing AMMONIA
Excipient focus: BUTYL ALCOHOL
doxercalciferol drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| West-Ward Pharmaceuticals Corp | doxercalciferol | 0054-0338 |
| >Company | >Ingredient | >NDC |
doxercalciferol drug variants not containing BUTYL ALCOHOL
Excipient focus: BUTYLATED HYDROXYANISOLE
doxercalciferol drug variants containing BUTYLATED HYDROXYANISOLE
doxercalciferol drug variants not containing BUTYLATED HYDROXYANISOLE
Excipient focus: BUTYLATED HYDROXYTOLUENE
doxercalciferol drug variants containing BUTYLATED HYDROXYTOLUENE
doxercalciferol drug variants not containing BUTYLATED HYDROXYTOLUENE
Excipient focus: D&C YELLOW NO. 10
doxercalciferol drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| West-Ward Pharmaceuticals Corp | doxercalciferol | 0054-0338 |
| Rising Pharmaceuticals Inc | doxercalciferol | 64980-228 |
| >Company | >Ingredient | >NDC |
doxercalciferol drug variants not containing D&C YELLOW NO. 10
Excipient focus: EDETATE DISODIUM
doxercalciferol drug variants containing EDETATE DISODIUM
doxercalciferol drug variants not containing EDETATE DISODIUM
Excipient focus: FD&C RED NO. 40
doxercalciferol drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| West-Ward Pharmaceuticals Corp | doxercalciferol | 0054-0338 |
| Winthrop US a business of sanofi-aventis US LLC | doxercalciferol | 0955-1720 |
| Rising Pharmaceuticals Inc | doxercalciferol | 64980-228 |
| >Company | >Ingredient | >NDC |
doxercalciferol drug variants not containing FD&C RED NO. 40
Excipient focus: FERRIC OXIDE YELLOW
doxercalciferol drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Winthrop US a business of sanofi-aventis US LLC | doxercalciferol | 0955-1720 |
| >Company | >Ingredient | >NDC |
doxercalciferol drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
doxercalciferol drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| West-Ward Pharmaceuticals Corp | doxercalciferol | 0054-0338 |
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | doxercalciferol | 23155-538 |
| Chartwell RX LLC | doxercalciferol | 62135-450 |
| Rising Pharmaceuticals Inc | doxercalciferol | 64980-228 |
| >Company | >Ingredient | >NDC |
doxercalciferol drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GELATIN
doxercalciferol drug variants containing GELATIN
doxercalciferol drug variants not containing GELATIN
Excipient focus: GLYCERIN
doxercalciferol drug variants containing GLYCERIN
doxercalciferol drug variants not containing GLYCERIN
Excipient focus: ISOPROPYL ALCOHOL
doxercalciferol drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| West-Ward Pharmaceuticals Corp | doxercalciferol | 0054-0338 |
| >Company | >Ingredient | >NDC |
doxercalciferol drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES
doxercalciferol drug variants containing MEDIUM-CHAIN TRIGLYCERIDES
doxercalciferol drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES
Excipient focus: POLYETHYLENE GLYCOL
doxercalciferol drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharmaceuticals Inc | doxercalciferol | 64980-228 |
| >Company | >Ingredient | >NDC |
doxercalciferol drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYSORBATE 20
doxercalciferol drug variants containing POLYSORBATE 20
doxercalciferol drug variants not containing POLYSORBATE 20
Excipient focus: POLYVINYL ACETATE PHTHALATE
doxercalciferol drug variants containing POLYVINYL ACETATE PHTHALATE
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharmaceuticals Inc | doxercalciferol | 64980-228 |
| >Company | >Ingredient | >NDC |
doxercalciferol drug variants not containing POLYVINYL ACETATE PHTHALATE
Excipient focus: PROPYLENE GLYCOL
doxercalciferol drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| West-Ward Pharmaceuticals Corp | doxercalciferol | 0054-0338 |
| Rising Pharmaceuticals Inc | doxercalciferol | 64980-228 |
| >Company | >Ingredient | >NDC |
doxercalciferol drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
doxercalciferol drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| West-Ward Pharmaceuticals Corp | doxercalciferol | 0054-0338 |
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | doxercalciferol | 23155-538 |
| Chartwell RX LLC | doxercalciferol | 62135-450 |
| >Company | >Ingredient | >NDC |
doxercalciferol drug variants not containing SHELLAC
Excipient focus: SODIUM ASCORBATE
doxercalciferol drug variants containing SODIUM ASCORBATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | doxercalciferol | 0641-6154 |
| >Company | >Ingredient | >NDC |
doxercalciferol drug variants not containing SODIUM ASCORBATE
Excipient focus: SODIUM CHLORIDE
doxercalciferol drug variants containing SODIUM CHLORIDE
doxercalciferol drug variants not containing SODIUM CHLORIDE
Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
doxercalciferol drug variants containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | doxercalciferol | 0641-6154 |
| Meitheal Pharmaceuticals Inc | doxercalciferol | 71288-802 |
| >Company | >Ingredient | >NDC |
doxercalciferol drug variants not containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
Excipient focus: SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
doxercalciferol drug variants containing SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
doxercalciferol drug variants not containing SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
Excipient focus: SODIUM PHOSPHATE, MONOBASIC
doxercalciferol drug variants containing SODIUM PHOSPHATE, MONOBASIC
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | doxercalciferol | 0641-6154 |
| >Company | >Ingredient | >NDC |
doxercalciferol drug variants not containing SODIUM PHOSPHATE, MONOBASIC
Excipient focus: SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
doxercalciferol drug variants containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
doxercalciferol drug variants not containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
Excipient focus: TITANIUM DIOXIDE
doxercalciferol drug variants containing TITANIUM DIOXIDE
doxercalciferol drug variants not containing TITANIUM DIOXIDE
Excipient focus: WATER
doxercalciferol drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| West-Ward Pharmaceuticals Corp | doxercalciferol | 0054-0338 |
| Hospira Inc | doxercalciferol | 0409-1331 |
| Hikma Pharmaceuticals USA Inc | doxercalciferol | 0641-6154 |
| >Company | >Ingredient | >NDC |
doxercalciferol drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
